No abstract available
Keywords:
Bangladesh; COVID-19; Post COVID; antimicrobial resistance (AMR); lower middle income countries (LMICs).
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use
-
Bangladesh / epidemiology
-
COVID-19*
-
Developing Countries
-
Drug Resistance, Bacterial*
-
Humans
-
SARS-CoV-2